Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR study von Gane, Edward J., Pockros, Paul J., Zeuzem, Stefan, Marcellin, Patrick, Shikhman, Anna, Bernaards, Coen, Zhou, Julian, Yetzer, Ellen S., Ballester, Rosa, Dwyer, Cindy, Tong, Xiao, Nájera, Isabel, Bertasso, Anne, Hammond, Janet, Kindrick, Amy, Morcos, Peter N., Smith, Patrick, Stancic, Saray, Shulman, Nancy S.

Volltext

The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy von Cooper, DA, Cordery, DV, Reiss, P, Henry, K, Nelson, M, O'Hearn, M, Reynes, J, Arastéh, K, Chung, J, Rowell, L, Guimaraes, D, Bertasso, A

Volltext

Adherence to Enfuvirtide and Its Impact on Treatment Efficacy von ROCKSTROH, Jürgen, DEJESUS, Edwin, THOMMES, James, ROWELL, Lucy, DEMASI, Ralph, SALGO, Miklos, DONATACCI, Lucille, WAT, Cynthia, BERTASSO, Anne, LABRIOLA-TOMPKINS, Emily, SHIKHMAN, Anna, ATKINS, Belinda, GUIMARAES, Denise, WILKINSON, Martin

Volltext

Antibodies to Borrelia burgdorferi and Bartonella species in serum and synovial fluid from people with rheumatic diseases von Kim, Lisa, Lashnits, Erin, Breitschwerdt, Edward B, Elam, Amanda, Grade, Neenah, Miller, Jennifer, Shikhman, Alexander R

Volltext